|
|
|
Corporate Profile: Nabi Biopharmaceuticals
| Summary: |
Nabi Biopharmaceuticals is focused on the develompment and commercialization of vaccines to prevent nicotine addiction and to prevent gram-positive bacterial infections.
|
| Address: |
12276 Wilkins Avenue
Rockville, MD 20852 |
| Phone
#'s: |
| Main |
(301) 770-3099 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(301) 770-3097 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known
|
| Human
Resources |
not known |
| Investor
Relations |
irpr@nabi.com |
| Financial
information: |
| NABI |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
